Study on Serum Zinc and Selenium Levels in Epileptic Patients

Arak University of Medical Sciences

Status: Completed

Conditions: Generalized Epileptic

Study type: Observational

Funder types: Other

Identifiers

NCT01764516

f110@19588 (Other Grant/Funding Number)

f110@1958

Details and patient eligibility

About

This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.

Full description

Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.

Enrollment: 40 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,

Exclusion criteria

presence of above criteria as well as, generalized and single epileptic cases under treatment

Trial design

40 participants in 6 patient groups

Zinc level (micro gram per deciliter)

Description:

In all cases

Selenium level (micro gram per deciliter)

Description:

In all cases

Zinc level in male (micro gram per deciliter)

Selenium level in male (micro gram per deciliter)

Zinc level in Female (micro gram per decilitre)

Selenium level in Female (micro gram per decilitre)